ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2015

Abstract Number: 280

The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases

Kentaro Noda, Ken Yoshida, Taro Ukichi, Kazuhiro Furuya, Kenichiro Hirai, Isamu Kingetsu and Daitaro Kurosaka, Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2015

Date of first publication: September 29, 2015

Keywords: autoimmune diseases, dermatomyositis, myositis and systemic lupus erythematosus (SLE)

Session Information

Date: Sunday, November 8, 2015

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We previously reported that inflammation
occurred early in the fascia of patients with dermatomyositis. We often
encounter patients with autoimmune diseases who present with muscle symptoms, such
as pain and weakness and biopsies of the affected muscle areas do not show
inflammatory cell infiltration among the muscle fibers, thereby leaving the
cause of these symptoms unclear. To date, the work-up for autoimmune disease
patients presenting with muscle symptoms has focused on the presence or absence
of muscle fiber inflammation, and not on the presence or absence of fasciitis.
Therefore,we thoroughly investigated the lesions of fasciae and muscles in
patients with muscle symptoms and elevated muscle enzyme levels.

Methods: This study included patients with autoimmune diseases who
presented with myalgia, muscle weakness, or elevated serum levels of muscle
enzymes (CK and aldolase), and were admitted to the Division of Rheumatology of
Jikei University School of Medicine Hospital between April 2007 and December
2013. They underwent magnetic resonance imaging (MRI) and en bloc
biopsy.

Results: Sixty-three patients presented with myalgia, muscle
weakness, and elevated levels of muscle enzymes (CK and aldolase), and
consisted of 26 with dermatomyositis (DM), 19 with polymyositis (PM), 9 with
clinically amyopathic dermatomyositis (CADM), 7 with systemic lupus
erythematosus (SLE), and 2 with adult-onset Still’s disease (AOSD). MRI was
performed in all sixty-three patients. Fascia involvement was observed in 45
(71.43%) of patients : in 23 (88.46%) out of 26 with DM, 7 (36.84%) out of 19
with PM, 6 (66.67%) out of 9 with CADM, all 7 with SLE, and all 2 with AOSD. Histopathological
examination was performed in thirty-five patients. Fasciitis was observed in 23
(65.71%) of patients�Fin 15 (83.33%) out of 18 with DM, 2 (25%) out of 8 with PM, 3 (50%)
out of 6 with CADM, and 3 (100%) out of 3 with SLE. Many patients with
fasciitis also had myalgia. However, myositis was not associated with myalgia.
Muscle weakness was not associated with fasciitis. A high percentage of
patients with normal serum CK levels and elevated serum aldolase levels,
developed fasciitis.

Conclusion: Fasciitis occurred in patients with various autoimmune
diseases. Patients with myalgia may have fasciitis in autoimmune diseases.


Disclosure: K. Noda, None; K. Yoshida, None; T. Ukichi, None; K. Furuya, None; K. Hirai, None; I. Kingetsu, None; D. Kurosaka, None.

To cite this abstract in AMA style:

Noda K, Yoshida K, Ukichi T, Furuya K, Hirai K, Kingetsu I, Kurosaka D. The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-fascia-is-a-target-organ-of-inflammation-in-autoimmune-diseases/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-fascia-is-a-target-organ-of-inflammation-in-autoimmune-diseases/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology